Philip J Bergman

Summary

Publications

  1. ncbi Anticancer vaccines
    Philip J Bergman
    Brightheart Veterinary Centers, 80 Business Park Drive, Suite 110, Armonk, NY 10504, USA
    Vet Clin North Am Small Anim Pract 37:1111-9; vi-ii. 2007
  2. ncbi Cancer immunotherapy
    Philip J Bergman
    BrightHeart Veterinary Centers Armonk, NY, USA
    Top Companion Anim Med 24:130-6. 2009
  3. ncbi Cancer immunotherapy
    Philip J Bergman
    Brightheart Veterinary Centers, 80 Business Park Drive, Armonk, NY 10504, USA
    Vet Clin North Am Small Anim Pract 40:507-18. 2010
  4. ncbi Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial
    Philip J Bergman
    Donaldson Atwood Cancer Clinic and Flaherty Comparative Oncology Laboratory, The E and M Bobst Hospital of the Animal Medical Center, New York, New York 10021, USA
    Clin Cancer Res 9:1284-90. 2003
  5. ncbi Clinical techniques in small animal molecular oncology
    Philip J Bergman
    Animal Medical Center, New York, NY 10021, USA
    Clin Tech Small Anim Pract 18:88-91. 2003
  6. ncbi Mechanisms of anticancer drug resistance
    Philip J Bergman
    Donaldson Atwood Cancer Clinic, Flaherty Comparative Oncology Laboratory, Animal Medical Center, 510 East 62nd Street, New York, NY 10021, USA
    Vet Clin North Am Small Anim Pract 33:651-67. 2003
  7. ncbi Vaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanoma
    Jack C F Liao
    Flaherty Comparative Oncology Laboratory, Donaldson-Atwood Cancer Clinic, The Animal Medical Center, New York, NY 10021, USA
    Cancer Immun 6:8. 2006

Collaborators

  • A N Houghton
  • Jack C F Liao
  • Jedd D Wolchok
  • Francesca Orlandi
  • Polly Gregor
  • Carrie Leung
  • Diane Craft

Detail Information

Publications7

  1. ncbi Anticancer vaccines
    Philip J Bergman
    Brightheart Veterinary Centers, 80 Business Park Drive, Suite 110, Armonk, NY 10504, USA
    Vet Clin North Am Small Anim Pract 37:1111-9; vi-ii. 2007
    ....
  2. ncbi Cancer immunotherapy
    Philip J Bergman
    BrightHeart Veterinary Centers Armonk, NY, USA
    Top Companion Anim Med 24:130-6. 2009
    ..Tumor immunology and immunotherapy is one of the most exciting and rapidly expanding fields at present...
  3. ncbi Cancer immunotherapy
    Philip J Bergman
    Brightheart Veterinary Centers, 80 Business Park Drive, Armonk, NY 10504, USA
    Vet Clin North Am Small Anim Pract 40:507-18. 2010
    ..This author looks forward to the time when immunotherapy plays a significant role in the treatment and/or prevention of cancer in human and veterinary patients...
  4. ncbi Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial
    Philip J Bergman
    Donaldson Atwood Cancer Clinic and Flaherty Comparative Oncology Laboratory, The E and M Bobst Hospital of the Animal Medical Center, New York, New York 10021, USA
    Clin Cancer Res 9:1284-90. 2003
    ..These studies provided the rationale for a trial of xenogeneic DNA vaccination in CMM using the human tyrosinase gene...
  5. ncbi Clinical techniques in small animal molecular oncology
    Philip J Bergman
    Animal Medical Center, New York, NY 10021, USA
    Clin Tech Small Anim Pract 18:88-91. 2003
    ..This review will summarize how to best utilize presently available tumor, node, and metastasis- and grading-based systems, and incorporate newly available molecular prognostic factors...
  6. ncbi Mechanisms of anticancer drug resistance
    Philip J Bergman
    Donaldson Atwood Cancer Clinic, Flaherty Comparative Oncology Laboratory, Animal Medical Center, 510 East 62nd Street, New York, NY 10021, USA
    Vet Clin North Am Small Anim Pract 33:651-67. 2003
    ....
  7. ncbi Vaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanoma
    Jack C F Liao
    Flaherty Comparative Oncology Laboratory, Donaldson-Atwood Cancer Clinic, The Animal Medical Center, New York, NY 10021, USA
    Cancer Immun 6:8. 2006
    ..Most interestingly, the onset of antibody induction in these three dogs coincides with observed clinical responses and may suggest a means to account for their long-term tumor control and survival...